Cancer/Oncology Drugs Market Revenue 2024 to 2034
Cancer/Oncology Drugs Market Revenue 2024 to 2034
The cancer/oncology drugs market will grow from USD 172.39 Bn in 2024 to USD 507.87 Bn by 2034, at an 11.41% CAGR, driven by targeted therapies, immuno-oncology, and rising global cancer prevalence.
Report ID: 10632
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 172.39 Bn
Forecast Year,
USD 507.87 Bn
CAGR, 2025 -
11.41%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Cancer/Oncology Drugs Market Size Analysis
Cancer/Oncology Drugs Market Size By Therapy 2024 to 2034 (USD )
| Therapy | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Targeted | 62.06 | 69.05 | 76.82 | 85.46 | 95.08 | 105.78 | 117.68 | 130.92 | 145.65 | 162.04 | 180.27 |
| Immunotherapy | 44.82 | 49.71 | 55.13 | 61.14 | 67.81 | 75.19 | 83.38 | 92.46 | 102.52 | 113.66 | 126.02 |
| Chemotherapy | 37.93 | 42.51 | 47.65 | 53.41 | 59.87 | 67.10 | 75.21 | 84.30 | 94.48 | 105.90 | 118.69 |
| Hormonal | 17.24 | 19.61 | 22.30 | 25.36 | 28.82 | 32.74 | 37.19 | 42.23 | 47.93 | 54.40 | 61.71 |
| Others | 10.34 | 11.18 | 12.07 | 13.01 | 14.01 | 15.07 | 16.19 | 17.36 | 18.59 | 19.86 | 21.19 |
Cancer/Oncology Drugs Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Lung | 37.93 | 41.76 | 45.97 | 50.61 | 55.71 | 61.32 | 67.49 | 74.28 | 81.75 | 89.96 | 98.99 |
| Breast | 34.48 | 38.48 | 42.94 | 47.91 | 53.47 | 59.66 | 66.58 | 74.29 | 82.90 | 92.50 | 103.21 |
| Colorectal | 24.13 | 27.20 | 30.66 | 34.54 | 38.91 | 43.83 | 49.35 | 55.57 | 62.55 | 70.40 | 79.22 |
| Prostate | 17.24 | 19.34 | 21.70 | 24.34 | 27.30 | 30.61 | 34.33 | 38.49 | 43.16 | 48.39 | 54.24 |
| Others | 58.61 | 65.28 | 72.71 | 80.99 | 90.20 | 100.47 | 111.90 | 124.63 | 138.82 | 154.62 | 172.21 |
Cancer/Oncology Drugs Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 82.75 | 92.20 | 102.74 | 114.48 | 127.57 | 142.15 | 158.39 | 176.50 | 196.67 | 219.15 | 244.19 |
| Retail | 58.61 | 65.54 | 73.29 | 81.96 | 91.66 | 102.50 | 114.63 | 128.20 | 143.38 | 160.35 | 179.34 |
| Online | 31.03 | 34.31 | 37.94 | 41.94 | 46.36 | 51.24 | 56.63 | 62.57 | 69.13 | 76.36 | 84.34 |
Cancer/Oncology Drugs Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 58.61 | 65.49 | 73.16 | 81.74 | 91.32 | 102.02 | 113.97 | 127.31 | 142.22 | 158.87 | 177.47 |
| Europe | 48.27 | 53.70 | 59.74 | 66.47 | 73.95 | 82.27 | 91.53 | 101.83 | 113.29 | 126.04 | 140.23 |
| Asia Pacific | 51.72 | 57.66 | 64.30 | 71.69 | 79.93 | 89.12 | 99.37 | 110.79 | 123.53 | 137.73 | 153.57 |
| Latin America | 6.90 | 7.40 | 7.92 | 8.48 | 9.05 | 9.66 | 10.28 | 10.92 | 11.58 | 12.25 | 12.92 |
| Middle East & Africa | 6.90 | 7.81 | 8.85 | 10.02 | 11.34 | 12.83 | 14.51 | 16.41 | 18.55 | 20.96 | 23.69 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
